AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Business Trip
Challenges in Treatment Rollout: A Controlled Approach and Reimbursement Concerns
This chapter explores the careful strategy required for the introduction of a new treatment following FDA discussions, emphasizing the anticipated challenges in drug delivery and potential hesitancy from insurance providers. The conversation highlights concerns about costs and the necessity for robust evidence, predicting a trend towards stricter regulations and gradual adoption in healthcare environments.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode